Area of research
Molecular Biology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cancer-related gene regulation, Diabetes Treatment and Management, Kruppel-like factors research, and Liver Disease Diagnosis and Treatment.
12,13-diHOME ameliorates MASLD by regulating Sestrin2-mediated AMPK/ULK1/Lipophagy in obese mice
Regional disparities and metabolic determinants of type 2 diabetes in women aged 55 and older.
RNA methylation in cardiovascular remodeling: Molecular mechanisms, biomarkers, and therapeutic strategies.
miR-210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential.
Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic Strategies.
The gut-brain axis in diabetic neuropathy, cognitive impairment, and emotional disorders.
STAT Signaling in Metabolic Disorders: From Molecular Mechanisms to Therapeutic Implications.
Epidemiological Trajectories and Quality of Care Disparities of MASLD in Asia, 1990-2023.
Microbiota-targeted modulation of the gut-kidney axis in diabetic kidney disease: Therapeutic advances and future perspectives.
Global Trends and Projections in Chronic Kidney Disease Burden from Diabetes, Hypertension, and Glomerulonephritis: A Population-Based Study.
Association between cardiometabolic index and thyroid function: insights from NHANES.
Temporal patterns and predictive factors of depressive disorders among adolescents and young people in Asia.
Temporal Patterns and Predictive Factors of Childhood Depressive Disorders Across Asia.
Trends and determinants of childhood anxiety disorders burden in Asia, 1990–2023
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023.
Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045.
Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment.
Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021.
Revolutionizing public health through digital health technology.
Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential.
The global, regional, and national burden and attributable risk factors of Alzheimer's disease and other dementias, 1990-2021: A systematic analysis for the Global Burden of Disease Study.
Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
Updated Insights on Childhood Diabetes Epidemiology 2019-2021 and Projections to 2045.
Flavonoids in Metabolic Disease: A Narrative Review of Mechanisms and Therapeutic Potential.
Aging-Related Obesity: Unveiling Mitochondrial and Metabolic Dysfunction.
Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies.
Association between urinary perchlorate and malignancies of endocrine-related tissues in U.S. adults: analysis of National Health and Nutrition Examination Survey (NHANES) data.
Editorial: Novel approaches to diet, exercise, and drugs in childhood obesity and metabolic diseases.